Search company, investor...

Lonza Biologics Tuas

Stage

Acquired | Acquired

About Lonza Biologics Tuas

Lonza Biologics Tuas was set-up in 2007 as joint venture between Lonza and Singapore government's Economic Development Board (EDB) as a large-scale cell culture manufacturing site for the production of monoclonal antibodies and recombinant proteins for biopharmaceuticals serving the pharmaceutical and biotechnology industries. Since 2009 it is a wholly owned company of Lonza Group.

Headquarters Location

35 Tuas South Ave 6

637377,

Singapore

+65 6521 4000

Missing: Lonza Biologics Tuas's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Lonza Biologics Tuas's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Lonza Biologics Tuas Patents

Lonza Biologics Tuas has filed 245 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Molecular biology
  • Transcription factors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/5/2018

3/21/2023

Biotechnology, Cell biology, Cell culture, Transcription factors, Stem cells

Grant

Application Date

10/5/2018

Grant Date

3/21/2023

Title

Related Topics

Biotechnology, Cell biology, Cell culture, Transcription factors, Stem cells

Status

Grant

Lonza Biologics Tuas Frequently Asked Questions (FAQ)

  • What is Lonza Biologics Tuas's latest funding round?

    Lonza Biologics Tuas's latest funding round is Acquired.

  • Who are the investors of Lonza Biologics Tuas?

    Investors of Lonza Biologics Tuas include Lonza Group and EDBI.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.